Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod vs Photodynamic Therapy for Actinic Cheilitis
NCT00849992Phase 4Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Mar 2009
- Primary completion
- Mar 2013
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of imiquimod in actinic cheilitis (AC), sponsored by Norwegian University of Science and Technology. Started Mar 2009; status: completed.
02
Drugs
imiquimod
03
Conditions
actinic cheilitis (AC)
Beyond the preview
Go deeper on NCT00849992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00849992.